Our Work

Artificial intelligence (AI) and novel technologies offer tremendous potential for improving the health of older adults, but how key stakeholders make decisions about which technology to finance and adopt is not well understood.

The impact of tariffs on prescription drug prices has been poorly understood.

Ambient AI “digital scribes” are rapidly moving into routine practice, easing documentation burden and physician burnout.